Академический Документы
Профессиональный Документы
Культура Документы
K is the proportion constant between the rate of change of the total drug in
body and the current amount of drug in body.
D = G + A + U + MU = U∞ + M∞ (1)
dA dG dU dM
= − + (2)
dt dt dt dt
D = A0 = A + U = U∞ = Ae∞ (3)
dA dU
− =K ·A= = CL · C (4)
dt dt
− dA = K · A − dC =K ·C
dt dt
A = A0 · e−K·t = D · e−K·t C= A
V = C0 · e−K·t = D
V · e−K·t
ln A = lnA − K · t
0
ln C = lnC0 − K · t
(6)
t
n= (7)
t 12
1
n
1
C = C0 · 2−n = C0 · (8)
2
ln 2 0.693
t 12 = = (9)
K K
A = U∞ − U = D − U (11)
dU
dt = ke · D − K · t
(12)
= ke · V · C0 − K · t
U = U∞ 1 − e−K·t = U∞ 1 − 2−n
(13)
ln (U∞ − U ) = ln U∞ − K · t (15)
D
CL = K · V = (17)
AU C
2
Analytical calculation
D C0
AU C = = (18)
CL K
Numerical Calculation:
∗ C∗
AU Ct→∞ = (19)
K
(C0 + C1 )(t1 − t0 ) C∗
AU C = + ··· + (20)
2 K
D = A0 = A + U + M + E = U∞ + M∞ + E∞ (21)
K = k e + km + k 0 (22)
dU
= ke A = ke · D · e−k·t = ke · V · C = CLr · C (25)
dt
dU
ln = ln(ke · D) − K · t (26)
dt
3
Instead of U∞ ke CLr
Substiture M∞ km CLm
Substiture E∞ k0 CLe
U∞ U0→t
CLr = ke · V = = (27)
AU C AU C0→t
U = U∞ 1 − e−K·t = U∞ 1 − 2−n
(28)
ln (U∞ − U ) = ln U∞ − K · t (29)
U∞ ke CLr ke
fe = = = ⇒ U∞ = fe · D = ·D (30)
D K CL K
For other pathways substitute
4
1.8 Hepatic Clearance
Rate of Extraction Q (CA − Cv ) CA − Cv
E= = = (34)
Rate of Presentation Q · CA CA
Q (CA − CV )
CLf = Q · E = (35)
CA
dM Vmax · C
= (36)
dt Km + C
dM
dt Vmax
CLin = = (37)
C Km + C
E+F = 1 Under certain assumptions.
U∞ CLr ke
fe = = = (39)
D CL K
M∞ CLm
fm = = (40)
D CL
0 E∞ CL0
f = = (41)
D CL
ml
0.5−0.8 min
z }| {
bile flow ·Concenrtation in bile
Bilary clearance = (42)
C
5
1.10 Elimination by metabolism
rate of extraction Q (CA − Cv ) CA − Cv
E= = = (43)
rate of presentation Q · CA CA
CLm = Q · E (44)
Q · fu · CLint
CLm = (45)
Q + fu · CLint
E + Fh = 1
dM Vmax [D]
=V = (47)
dt [D] + Km
Competitive Inhibition
V [D]
V = max (48)
[I]
D+ 1+ K I
Km
Noncompetitve Inhibition
Vmax [D]
V = (49)
[I]
(D + Km ) 1 + KI
6
2 Extravascular Administration (single dose)
dG
− = ka · G (50)
dt
ln G = ln G0 − ka · t (52)
ln 2
t 1 absorption = (53)
2 ka
F · D · ka
e−K·t − e−ka·t
C= (55)
V (ka − K)
| {z }
A00
ln ka
K
tmax = (56)
ka − K
F · D −K·tmax
Cmax = e (57)
V
7
2.3 Pharmacokinetics parameters
F ·D
CL = K · V = (58)
AU C
Z t
AU C = C · dt (59)
0
U∞
CLr = (60)
AU C
ln C = ln A00 − K · t (62)
ln (C 0 − C) = ln A00 − ka · t (64)
2.5 ka ≈ K
Dost Equation
K · F · D · t −K·t
C= e (65)
V
1
K = ka = (66)
tmax
8
1
tmax = (67)
K
F ·D
Cmax = (68)
V ·e
AU C
Cmax · tmax = (69)
e
ln ka
K
tmax = t0 + (71)
ka − K
dU F · D · ka h −K(t) −ka(t)
i
= ke e −e (73)
dt (ka − K)
F · D · ka
A0 = k e (74)
(ka − K)
dU
= A0 e−K·t − e−ka·t
(75)
dt
U∞
fe = (76)
F ·D
9
3 Zero Order Input and First Order Output
G = G 0 − k0 · t = D − k0 · t (78)
F ·D
t 1 Absorption = (79)
2 2k0
dA
= k0 − K · V · C = k0 − CL · C (81)
dt
Ass k0 k0
Css = = = (84)
V K ·V CL
10
3.4 Before Steady state
F · k0
1 − e−K·t = Ass 1 − e−K·t = Ass 1 − 2−n
A= (85)
K
F · k0
1 − e−K·t = Css 1 − e−K·t = Css 1 − 2−n
C= (86)
CL
t K ·t
n= = (87)
t 12 ln 2
DL F · k 0
C = Css + − e−K·t (89)
V CL
F · k0 F · k0
D∗ = Css · V = V = (90)
CL K
0
t = T + t0 ⇒ C = Cmax eK·t = Cmax e−K(t−T ) (92)
←−
G0 D (93)
T = k0 = k0 G = 0 G = G0 − k0 · t
11
3.7 Urine Data
During infusion
dU k0
1 − e−K·t = ke · Ass 1 − e−K·t
= ke (94)
dt K
ke
fe = (95)
K
dU
= fe · k0 1 − e−K·t
(96)
dt
4 Bioavailability
Absolute Bioavailability
AU CP O
DP O if Div =DP O AU CP O
F = AU CIV
−→ F = (99)
DIV
AU CIV
Relative Bioavailability
AU CT est
DT est if DRef =DT est AU CT est
F = AU CRef
−→ F = (100)
AU CRef
DRef
12
4.2 Urine Data
U∞P O
DP O if DRef =DT est U∞P O
F = U∞IV
−→ F = (101)
U∞IV
DIV
D
C̄ss = (104)
CL · τ
D D 1 − e−n·k·τ 1 − e−n·k·τ
Cmax(n) = S= · = Cmax(1) = Cmax(1) S (105)
V V 1 − e−k·τ 1 − e−k·τ
D
Cmax(n) − Cmin(n) = · S · (1 − e−k·τ ) (107)
V
D 1 − en·k·τ −kt
C(n)t (0≤t≤τ ) = −k·τ
· e = Cmax(n) e−k·t (108)
V 1−e
13
D D
C = =
SSmax V (1−e−kτ ) V (1−2−n )
D·e−kτ
CSSmin = V (1−e−kτ )
= CSSmax · e−k·τ
= CSSmax · e−k·t
C
SS,t
(109)
ASS,max = (1−eD−kτ ) = (1−2
D
−n )
D·e−kτ
ASS,min = (1−e −kτ )
A −A
SS,max =F ·D
SS,min
F ·D F ·D 1.44 · D · t 12 F
Āss = = ln 2 = (111)
·K · τ t1 · τ
τ
2
14
Cupper − Clower
C̄SS,av = Cupper
(116)
ln Clower
F ·D F ·D
ASS,max = CSS,max · V = = (121)
(1 − e−Kτ ) (1 − 2−m )
F · D · e−kτ F · D · 2−m
ASS,min = CSS,min · V = = (122)
(1 − e−Kτ ) (1 − 2−m )
τ
m= t1
2
F ·D t 12
ĀSS = = 1.44 · · F · D (123)
K ·τ τ
15
D
= Dosing Rate (125)
τ
CSS,max
= eKτmax (127)
CSS,min
1 CSS,max
τmax = ln (When ka K) (128)
K CSS,min
V ASS,max ASS,min
Dm = (CSS,max − CSS,min ) = − (129)
F F F
V
Dm F (CSS,max − CSS,min )
= C
(130)
τmax 1
ln CSS,max
K SS,max
6.2 Fluctuations
CSS,max −CSS,min
Fluctuation Ratio = 100 · CSS,min
CSS,max −CSS,min
IV Bolus Fluctuation Index = 100 · (131)
C̄SS
AUC Fluctuation = 100 · AU Cabove −AU Cbelow
AU CSS
ASS,max
F luctuation = = ek·τ (132)
ASS,min
16
7 Protein Binding
Cb Cu (133)
fb = C fu = C fu + fb = 1
1 [DP ]
ka = = (134)
kd [D][P ]
n · ka[D]
r= (136)
1 + ka[D]
where n is the number of binding sites.
1 1 + ka[D] 1 1
= = + (138)
r n · ka[D] n · ka[D] n
r
= n · ka − ka · r (139)
[D]
Cbound
= n · [P ]t · ka − ka · Cb (140)
Cunbound
A A
V = ; Vu = (141)
C Cu
17
[P ] 1
fu p = ; fu = (142)
[P ]t 1 + ka[P ]
VT W · fu VT W · fu
V = Vp + ≈ (143)
fuT fuT
A · fuT
Cu = (144)
VT
T BW 42
% of unbound drug in the body = Vu · 100 = Vu · 100
k10 = ke + km + k 0 (145)
C = A · e−α·t + B · e−β·t
αβ;After some time
−→ (146)
C = B · e−β·t
A B
AU C = + (149)
α β
18
8.1 Pharmacokinetical parameters
ln 2 ln 2 (151)
t 12 α = α t 12 β = β
D
CL = = k10 · V1 (152)
AU C
CL D
Vβ = = (153)
β AU C · β
A B
k12
D α2 + β2
VSS = V1 + VT = V1 1 + = 2 (154)
k21 A B
α + β
8.3 Extravascular
A B P
AU C = + + (158)
α β π
where α > β > π .
19
8.5 Renal Clearance
du
= CLr · C (159)
dt
U∞ CLr ke
fe = = = (160)
D CL K
M∞ CLm
fm = = (161)
D CL
0 E∞ CL0
f = = (162)
D CL
9 Elimination by Metabolism
Q · fu · CLint
CLm = Q · E = (165)
Q + fu · CLint
10 Clinical Pharmacokinetics
20
E = E0 − K · m · t (167)
1 1
td = (ln C0 · V − ln Cmin · V ) = (ln D − ln Amin ) (170)
K K
t 12
1 D D
td = ln = ln (171)
K Amin ln 2 Amin
11 Metabolite Kinetics
kf k(m)
A −→ M −→ U (172)
dM i.v.bolus
= kf · A − k(m) · M −→ kf · De−Kt − k(m) · M (173)
dt
kf DF
e−Kt − e−k(m) t
M= (174)
k(m) − K
kf CLf M∞
fm = = = (175)
K CL D
21
11.1 Metabolite that appears in plasma only and not in urine
(AU Cm )D CLf fm · CL
= = (176)
AU C CL(m) CL(m)
(AU Cm )D
D
M.W
fm = AU Cm
(177)
M
M.W
fm · F · D
CL(m) = (178)
AU C(m) D
dM
= kf · A − k(m) M = CLf · C − CL(m) Cm (179)
dt
kf · ASS kf k0 fm · k0
MSS = = · = (180)
k(m) K k(m) k(m)
Cm,ss CLf
= (183)
CSS CL(m)
fm · k0
MSS = (184)
k(m)
22
¯ = fm · F · D Formation rate of metabolism
Cm,ss,av = CmSS = (186)
CL(m) · τ CL(m)
¯ = AU Csingle
CSS,av (187)
τ
¯ AU C(m),single
Cm,SS,av = (188)
τ
AU C(m) D Fm · CL CLf
= = (189)
AU C CL(m) CL(m)
Low E
F ·D F ·D
C̄SS = = (190)
CL · τ fU · CLint · τ
fU · F · D F ·D
C̄USS = fU · C¯SS = = (191)
fU · Clint · τ CLint · τ
n · MW
Ael(mg) = (193)
NA
R∞
0 t · dAel
M RT = (194)
Ael
| {z∞}
Dose
Where Ael∞ = M∞ + U∞ + E∞ = Dose
23
RN
0 (Dose − Ael)dt
M RT = (195)
Dose
AU M C 1 1
M RTP.O = = + (196)
AU C ka K
c∗t∗ c∗
AU M C extrapolated = k + k2
T 1
M RTinf usion = + (197)
2 K
T
M RTi.v = M RTinf usion − (198)
2
D · AU M C
VSS = CL · M RTi.v bolus = (199)
AU C 2
k0 · T · AU M C k0 · T 2
VSS = − (200)
AU C 2 2AU C
M RTT ablet − M RToral solution = Mean dissolution time (in vivo) (204)
24
M RTT ablet − M RTpowder = Mean disintegration time (in vivo) (205)
A B
D · AU M C α2 + β 2
VSS = = 2 (207)
AU C 2 A B
α + β
1 1 1
M RT = + − (208)
α β k21
25